CAR-T cell therapy in Multiple Myeloma: current status and future challenges
Abstract The treatment of multiple myeloma has changed dramatically in recent years, with huge strides forward made in the field. Chimeric antigen receptor T-cell therapy targeting the B cell maturation antigen (BCMA) is now widely approved in relapsed refractory patients and is moving into earlier...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2024-11-01
|
| Seri Bilgileri: | Blood Cancer Journal |
| Online Erişim: | https://doi.org/10.1038/s41408-024-01191-8 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|